If you are interested in joining the study, or would like further information, please contact Elizabeth Button at email@example.com
- RSV ComNet II January 2021-September 2021
- RSV ComNet III (part 1) October 2021-July 2022
- RSV ComNet III (part 2) November 2022-ongoing
- Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in children. Almost all children get it.
- Most cases are mild but some end up with serious complications. Hospitalisation rates are higher in younger children.
- Accurate estimates of the burden of RSV in primary care are necessary to assess the overall impact of RSV on society.
- This knowledge is critical for policymakers to make informed decisions regarding the introduction of new RSV interventions.
- Comparative RSV ComNet studies are also being conducted in the Netherlands, Italy, Spain, France and Belgium.
- The aim of RSV ComNet is to measure the clinical and socio-economic disease burden of RSV in young children (aged <5 years) in primary care.
- Be part of the Oxford-RCGP RSC network
- Sign up to virology swabbing surveillance
- Be willing to swab eligible <5 year olds
- Be able to obtain parental/guardian informed consent
- Be able to complete 2 short telephone questionnaires using an online survey
- Be in touch with your local Clinical Research Network (CRN)
- Chief Investigator: University of Oxford (Professor Simon de Lusignan)
- Sponsor: Netherlands Institute for Health Services Research (NIVEL)
- Lead CRN: Thames Valley and South Midlands
Central Portfolio Management System (CPMS) ID: 47281